TL;DR: Aetna, a CVS Health company, modified CPB 0530 governing transvaginal ultrasonography coverage, with an effective date of September 26, 2025. Billing teams using CPT 76817 and 76830 need to verify their diagnosis coding maps against 21 updated medical necessity indications before claims go out.
This update to the Aetna transvaginal ultrasonography coverage policy touches a wide range of OB/GYN and reproductive medicine billing scenarios. CPB 0530 Aetna now lays out a detailed, indication-specific framework for when TV-US is covered versus when it isn't — and the Doppler exclusion for Lynch II and BRCA monitoring is the kind of specific carve-out that generates denials if your team misses it. Here's what you need to know.
| Field | Detail |
|---|---|
| Payer | Aetna, a CVS Health company |
| Policy | Transvaginal Ultrasonography — CPB 0530 |
| Policy Code | CPB 0530 |
| Change Type | Modified |
| Effective Date | September 26, 2025 |
| Impact Level | Medium-High |
| Specialties Affected | OB/GYN, Reproductive Endocrinology & Infertility, Maternal-Fetal Medicine, Gynecologic Oncology, Radiology |
| Key Action | Audit charge capture for CPT 76817 and 76830 against the 21 covered indications; flag Doppler mode claims for Lynch II and BRCA patients before billing |
Aetna Transvaginal Ultrasonography Coverage Criteria and Medical Necessity Requirements 2025
The Aetna transvaginal ultrasonography coverage policy under CPB 0530 defines medical necessity across 21 distinct clinical indications. This is an indication-driven policy. "Pelvic pain" alone doesn't get you there — Aetna requires pelvic pain of suspected gynecologic origin to meet medical necessity for TV-US.
CPT 76830 (non-obstetrical transvaginal ultrasound) and CPT 76817 (pregnant uterus, transvaginal) are both covered when the documentation supports one of the listed indications. These are the two codes with direct coverage criteria under CPB 0530. The remaining codes — CPT 76801, 76802, 76856, and 76857 — are listed as related codes, not independently covered codes under this policy.
Your documentation needs to match the specificity of the criteria. For example, Aetna covers TV-US for evaluation of women with new symptoms — bloating, difficulty eating or feeling full quickly, pelvic or abdominal pain, or urinary frequency and urgency — but only when those symptoms have persisted for three or more weeks, a pelvic and rectal exam has already been performed, and the clinician suspects ovarian cancer. That's a three-part test buried in one indication. Your coders need to know it's there.
The policy also covers TV-US for IUD position verification, but only when the IUD string is not visible or there's a reason to suspect the device is out of position. Routine IUD checks don't meet medical necessity under this policy.
Prior authorization requirements for transvaginal ultrasonography vary by plan. Check the member's specific plan benefits before scheduling, especially for infertility monitoring and genetic surveillance indications — those are the claims most likely to trigger prior auth review.
Aetna Transvaginal Ultrasonography Exclusions and Non-Covered Indications
There's one specific exclusion buried in this policy that your team needs to flag immediately. Aetna considers Doppler ultrasound mode not medically necessary when performing TV-US to monitor women with Lynch II syndrome or BRCA mutations for ovarian cancer.
The standard TV-US for Lynch II and BRCA monitoring is covered. Add Doppler, and you've crossed into non-covered territory. This is the same kind of modality-specific exclusion Aetna has used in other imaging policies — the procedure is covered, but the enhanced mode is not. If your system defaults to Doppler-inclusive protocols for high-risk surveillance patients, you'll generate a claim denial. Fix the protocol before September 26, 2025.
Coverage Indications at a Glance
| Indication | Status | Relevant CPT Codes | Notes |
|---|---|---|---|
| Fetal viability / gestational age — first trimester uncertainty or viability risk | Covered | 76817 | Documentation must show uncertainty about dates or risk of pregnancy failure |
| Pelvic mass assessment (adenomyosis, cancer, cyst, fibroid) | Covered | 76830 | ICD-10 D25.x, D27.x, N83.x apply |
| Retained products of conception / incomplete miscarriage | Covered | 76830, 76817 | — |
| Diagnosis of bowel endometriosis | Covered | 76830 | ICD-10 N80.50–N80.569 |
| Ectopic pregnancy or pregnancy of unknown location | Covered | 76817, 76830 | — |
| Vasa previa diagnosis | Covered | 76817 | — |
| Abnormal uterine bleeding | Covered | 76830 | — |
| Congenital uterine anomalies | Covered | 76830 | — |
| First-trimester bleeding and pain | Covered | 76817 | — |
| Infertility evaluation | Covered | 76830 | — |
| Pelvic pain of suspected gynecologic origin | Covered | 76830 | "Suspected gynecologic origin" is required — not pelvic pain alone |
| Sequelae of pelvic infection (abscess, hydrosalpinx) | Covered | 76830 | ICD-10 N70.01–N77.1 applies |
| Suspected molar pregnancy or gestational trophoblastic disease | Covered | 76817, 76830 | ICD-10 C58, D39.2 |
| Cervical evaluation for preterm birth risk | Covered | 76817 | Patient must have preterm labor symptoms OR high risk for cervical insufficiency |
| New symptoms (bloating, eating difficulty, pelvic/abdominal pain, urinary urgency) persisting 3+ weeks with prior pelvic/rectal exam and suspected ovarian cancer | Covered | 76830 | Three-part requirement — document all three elements |
| Post-menopausal bleeding | Covered | 76830 | — |
| Embryo transfer guidance | Covered | 76830 | — |
| Abnormal transabdominal obstetric ultrasound requiring further detail | Covered | 76817 | Must document why transabdominal was insufficient |
| Follicular development monitoring during infertility therapy | Covered | 76857 | Natural or stimulated cycles |
| Lynch II syndrome or BRCA mutation — ovarian cancer surveillance | Covered (standard mode only) | 76830 | Doppler mode is NOT covered for this indication |
| IUD position verification | Covered | 76830 | String must be non-visible OR position suspected incorrect — not routine |
Aetna Transvaginal Ultrasonography Billing Guidelines and Action Items 2025
Transvaginal ultrasonography billing under CPB 0530 is straightforward when documentation is tight. It falls apart fast when coders rely on vague diagnosis coding or when protocols haven't been updated to reflect indication-specific criteria.
| # | Action Item |
|---|---|
| 1 | Audit your ICD-10 crosswalk for CPT 76817 and 76830 before September 26, 2025. Map each code to the specific indication it supports. A claim for 76830 billed with a generic pelvic pain code (without documentation of suspected gynecologic origin) will deny. |
| 2 | Flag all Doppler TV-US claims for Lynch II and BRCA patients immediately. If your department runs Doppler-inclusive protocols for high-risk surveillance, update those protocols now. Bill CPT 76830 without Doppler for these patients. Document that standard mode was used. |
| 3 | Verify the three-part requirement for suspected ovarian cancer in symptomatic patients. The note needs to confirm: symptoms persisted three or more weeks, a pelvic and rectal exam was performed, and the clinician suspects ovarian cancer. All three. Missing one element is a denial waiting to happen. |
| 4 | Check IUD verification claims against the coverage standard. Routine IUD checks don't qualify. The medical record needs to document that the string was not visible or that malposition was clinically suspected. If that documentation isn't there, the claim won't hold. |
| 5 | Confirm prior authorization requirements by plan for infertility monitoring and genetic surveillance. Reimbursement for follicular monitoring (CPT 76857) and Lynch II/BRCA surveillance (CPT 76830) may require prior auth depending on the specific Aetna plan. Pull the plan details before the service date — not after a denial. |
| 6 | Educate providers on specificity requirements for the "new symptom" ovarian cancer indication. Clinicians need to document the duration of symptoms, the exam performed, and their clinical suspicion explicitly. Generic notes won't support this indication at appeal. |
If you're billing for a high-volume OB/GYN or REI practice, run a 90-day lookback on TV-US claims for Lynch II, BRCA, and IUD-related encounters. Find out if any were billed with Doppler or without meeting the documented criteria. That tells you the scope of your exposure. Talk to your compliance officer if the volume is significant — this is worth a focused review before the effective date.
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Transvaginal Ultrasonography Under CPB 0530
Covered CPT Codes (When Selection Criteria Are Met)
| Code | Type | Description |
|---|---|---|
| 76817 | CPT | Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
| 76830 | CPT | Ultrasound, transvaginal (non-obstetrical) [except for confirmation of placement of an intrauterine device] |
Other CPT Codes Related to CPB 0530
These codes appear in the policy as related codes. They are not independently covered under CPB 0530's selection criteria, but they appear in the same clinical context and may apply depending on the service rendered.
| Code | Type | Description |
|---|---|---|
| 76801 | CPT | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, first trimester |
| 76802 | CPT | Each additional gestation (list separately in addition to code for primary procedure) |
| 76856 | CPT | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
| 76857 | CPT | Ultrasound, pelvic (nonobstetric), real time with image documentation; limited or follow-up (e.g., for follicles) |
Key ICD-10-CM Diagnosis Codes
This policy maps to 362 ICD-10-CM codes. Below are the primary codes referenced in the policy data. Use these to build your diagnosis crosswalk. If you're billing for a condition not represented here, confirm coverage before submitting.
| Code | Description |
|---|---|
| C53.0–C53.9 | Malignant neoplasm of cervix uteri |
| C55 | Malignant neoplasm of uterus |
| C56.1–C56.9 | Malignant neoplasm of ovary |
| C57.4 | Malignant neoplasm of uterine adnexa, unspecified |
| C58 | Malignant neoplasm of placenta |
| C79.60–C79.63 | Secondary malignant neoplasm of ovary |
| C79.82 | Secondary malignant neoplasm of genital organs |
| D07.0 | Carcinoma in situ of endometrium |
| D25.0–D25.9 | Leiomyoma of uterus (fibroid) |
| D26.1 | Other benign neoplasm of corpus uteri |
| D27.0–D27.9 | Benign neoplasm of ovary |
| D39.0 | Neoplasm of uncertain behavior of uterus |
| D39.10–D39.12 | Neoplasm of uncertain behavior of ovary |
| D39.2 | Neoplasm of uncertain behavior of placenta |
| N39.3–N39.9 | Urinary incontinence (female) |
| N70.01–N77.1 | Inflammatory diseases of female pelvic organs |
| N80.0–N80.3 | Endometriosis of uterus |
| N80.50–N80.569 | Endometriosis of intestine (bowel) |
| N83.201–N83.207 | Other and unspecified ovarian cysts |
The full list of 362 covered ICD-10-CM codes is available in CPB 0530 on the Aetna clinical policy portal. Build your charge capture crosswalk from the complete list — not just the subset above.
Get the Full Picture for CPT 76817
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.